Susan Mesco | Pacira Pharmaceuticals, Inc. |
David Stack | Pacira Pharmaceuticals, Inc. |
Richard E. Scranton | Pacira Pharmaceuticals, Inc. |
Charles A. Reinhart III | Pacira Pharmaceuticals, Inc. |
Ashley Ryu | RBC Capital Markets LLC |
David A. Amsellem | Piper Jaffray & Co. |
Dana Flanders | Goldman Sachs & Co. LLC |
Oren Livnat | H. C. Wainwright & Co. LLC |
David Michael Steinberg | Jefferies LLC |
Good day, ladies and gentlemen and welcome to the Q1 2018 Pacira Pharmaceuticals, Inc. Conference Call. Currently at this time all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will follow at that time. (00:00:17-00:00:26) I would like to turn the call over to your host, to Susan Mesco, Head of Investor Relations.